Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protein arginine methyltransferase 8 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | histone arginine methyltransferase PRMT4/CARM1 | protein arginine methyltransferase 8 | 385 aa | 345 aa | 33.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0071 | 0.4509 | 0.8303 |
Entamoeba histolytica | protein kinase, putative | 0.0106 | 0.9099 | 0.909 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.2839 | 0.2765 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0071 | 0.4509 | 0.6497 |
Entamoeba histolytica | protein kinase, putative | 0.0113 | 1 | 1 |
Entamoeba histolytica | arginine N-methyltransferase protein, putative | 0.0058 | 0.2839 | 0.2765 |
Echinococcus granulosus | protein arginine N methyltransferase 8 | 0.0037 | 0.0162 | 0.0114 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.007 | 0.4408 | 0.8113 |
Echinococcus granulosus | nervana 2 | 0.007 | 0.4408 | 0.8113 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Trichomonas vaginalis | protein arginine N-methyltransferase, putative | 0.0037 | 0.0162 | 0.0162 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Trichomonas vaginalis | protein arginine N-methyltransferase, putative | 0.0037 | 0.0162 | 0.0162 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0071 | 0.4509 | 1 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.007 | 0.4408 | 0.8113 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0078 | 0.541 | 1 |
Echinococcus multilocularis | protein arginine methyltransferase | 0.0037 | 0.0162 | 0.0114 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0106 | 0.9099 | 0.909 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0078 | 0.541 | 1 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0071 | 0.4509 | 0.8303 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0101 | 0.0101 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0113 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0101 | 0.0101 |
Trichomonas vaginalis | AGC family protein kinase | 0.0043 | 0.1002 | 0.1002 |
Trypanosoma cruzi | Protein kinase B | 0.0078 | 0.541 | 1 |
Entamoeba histolytica | protein kinase 2, putative | 0.0071 | 0.4509 | 0.4453 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0078 | 0.541 | 0.5363 |
Trichomonas vaginalis | protein arginine N-methyltransferase, putative | 0.0037 | 0.0162 | 0.0162 |
Leishmania major | arginine N-methyltransferase-like protein | 0.0037 | 0.0162 | 0.5 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0078 | 0.541 | 0.5363 |
Echinococcus multilocularis | nervana 2 | 0.007 | 0.4408 | 0.8113 |
Entamoeba histolytica | protein kinase, putative | 0.0113 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.2839 | 0.2765 |
Giardia lamblia | Kinase, AGC PKA | 0.0071 | 0.4509 | 0.5 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.007 | 0.4408 | 0.8113 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0101 | 0.0101 |
Toxoplasma gondii | AGC kinase | 0.0106 | 0.9099 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0078 | 0.541 | 1 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0071 | 0.4509 | 0.8303 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0071 | 0.4509 | 1 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0113 | 1 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0078 | 0.541 | 1 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0106 | 0.9099 | 0.909 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Schistosoma mansoni | protein arginine N-methyltransferase 1 | 0.0037 | 0.0162 | 0.0114 |
Echinococcus granulosus | nervana 2 | 0.007 | 0.4408 | 0.8113 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.007 | 0.4408 | 0.8113 |
Schistosoma mansoni | protein arginine N-methyltransferase 1 | 0.0037 | 0.0162 | 0.0114 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0078 | 0.541 | 1 |
Echinococcus granulosus | protein arginine methyltransferase | 0.0037 | 0.0162 | 0.0114 |
Brugia malayi | hypothetical protein | 0.0058 | 0.2839 | 0.2765 |
Trichomonas vaginalis | AGC family protein kinase | 0.0113 | 1 | 1 |
Echinococcus multilocularis | protein arginine N methyltransferase 8 | 0.0037 | 0.0162 | 0.0114 |
Schistosoma mansoni | protein arginine N-methyltransferase 1 | 0.0037 | 0.0162 | 0.0114 |
Echinococcus multilocularis | nervana 2 | 0.007 | 0.4408 | 0.8113 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Activity at PRMT6 (unknown origin) using AdoMet assessed as formation of MMA and aDMA at 0.25 to 200 uM after 60 to 120 mins by LC-MS/MS analysis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT4 (unknown origin) using AdoMet assessed as formation of MMA and aDMA at 0.25 to 200 uM after 60 to 120 mins by LC-MS/MS analysis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT4 (unknown origin) using [methyl-14C]AdoMet at 0.25 to 200 uM after 60 to 120 mins by tricine gel electrophoresis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT1 (unknown origin) using AdoMet assessed as formation of MMA and aDMA at 0.25 to 200 uM after 60 to 120 mins by LC-MS/MS analysis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT1 (unknown origin) assessed as methylation of substituted arginines by LC-MS/MS analysis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT6 (unknown origin) assessed as methylation of substituted arginines by LC-MS/MS analysis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT6 (unknown origin) using [methyl-14C]AdoMet at 0.25 to 200 uM after 60 to 120 mins by tricine gel electrophoresis | ChEMBL. | No reference | |
Activity (binding) | Activity at PRMT1 (unknown origin) using [methyl-14C]AdoMet at 0.25 to 200 uM after 60 to 120 mins by tricine gel electrophoresis | ChEMBL. | No reference | |
Ki (binding) | = 4.29 uM | Inhibition of PRMT1 (unknown origin) using AdoMet by Michaelis-Menten equation analysis | ChEMBL. | No reference |
Ki (binding) | = 31.3 uM | Inhibition of PRMT6 (unknown origin) using AdoMet by Michaelis-Menten equation analysis | ChEMBL. | No reference |
Km (binding) | = 1.76 uM | Activity at PRMT6 (unknown origin) up to 40 uM using AdoMet by Michaelis-Menten equation analysis | ChEMBL. | No reference |
Km (binding) | = 5.23 uM | Activity at PRMT1 (unknown origin) up to 40 uM using AdoMet by Michaelis-Menten equation analysis | ChEMBL. | No reference |
Vmax (binding) | = 11.9 pmol/min | Activity at PRMT6 (unknown origin) up to 40 uM using AdoMet by Michaelis-Menten equation analysis | ChEMBL. | No reference |
Vmax (binding) | = 91.2 pmol/min | Activity at PRMT1 (unknown origin) up to 40 uM using AdoMet by Michaelis-Menten equation analysis | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.